Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Evofem Biosciences(EVFM) the Revenue is 2.633 M (-45.43%);the EBIT is -2.489 M (-98.96%);the EPS is -0.0811 (-447.8%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.00B45.43%
----
----
EBIT
-0.00B98.96%
----
----
EPS
-0.0811447.75%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf